CycloPhore™ & SemaPhore™ Enabling Next-Generation Delivery Solutions for Circular RNA & mRNA therapeutics

• Explore how CycloPhore™ and SemaPhore™ overcome delivery barriers to enable the extrahepatic delivery of circular RNA and mRNA
• Understand the platform’s potential for improving stability, targeting, and translational efficiency of RNA therapeutics
• Learn how patented delivery technologies are advancing the development of novel RNA modalities

Speakers:

Covadonga Paneda

Chief Operating Officer

Altamira Therapeutics